Lessons from SAVOR and EXAMINE: some important answers, but many open questions.
Department of Medicine I, Rudolfstiftung Hospital, Vienna, Austria; Institute of Cardiovascular & Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University Of Glasgow. Electronic address: guntram.schernthaner@meduniwien.ac.at.
Guntram
G
Schernthaner
Department of Medicine I, Rudolfstiftung Hospital, Vienna, Austria; Institute of Cardiovascular & Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University Of Glasgow.
Naveed
N
Sattar
D000218:Adamantane / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000139:chemically induced* / Q000150:complications / Q000517:prevention & control; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D003925:Diabetic Angiopathies / Q000139:chemically induced* / Q000517:prevention & control; D058065:Diabetic Cardiomyopathies / Q000139:chemically induced* / Q000517:prevention & control; D004151:Dipeptides / Q000009:adverse effects / Q000627:therapeutic use; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D019317:Evidence-Based Medicine; D006801:Humans; D010880:Piperidines / Q000009:adverse effects / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D014498:Uracil / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use
D004151:Dipeptides; D054873:Dipeptidyl-Peptidase IV Inhibitors; D010880:Piperidines; D014498:Uracil; C502994:saxagliptin; C520853:alogliptin; D000218:Adamantane